Total Liabilities Summary of Abnova (Taiwan) Corporation

Abnova (Taiwan) Corporation's latest annual total liabilities in 2023 was 69.42 Million TWD , down -16.19% from previous year.
Abnova (Taiwan) Corporation's latest quarterly total liabilities in 2024 Q2 was 82.36 Million TWD , down -24.29% from previous quarter.
Abnova (Taiwan) Corporation reported annual total liabilities of 82.83 Million TWD in 2022, up 16.19% from previous year.
Abnova (Taiwan) Corporation reported annual total liabilities of 71.29 Million TWD in 2021, down -14.61% from previous year.
Abnova (Taiwan) Corporation reported quarterly total liabilities of 82.36 Million TWD for 2024 Q2, down -24.29% from previous quarter.
Abnova (Taiwan) Corporation reported quarterly total liabilities of 86.04 Million TWD for 2023 Q3, down -40.21% from previous quarter.

Annual Total Liabilities Chart of Abnova (Taiwan) Corporation (2023 - 2009)

Historical Annual Total Liabilities of Abnova (Taiwan) Corporation (2023 - 2009)

Year	Total Liabilities	Total Liabilities Growth
2023	69.42 Million TWD	-16.19%
2022	82.83 Million TWD	16.19%
2021	71.29 Million TWD	-14.61%
2020	83.49 Million TWD	16.63%
2019	71.58 Million TWD	5.64%
2018	67.76 Million TWD	-14.28%
2017	79.05 Million TWD	9.71%
2016	72.05 Million TWD	-12.5%
2015	82.35 Million TWD	5.37%
2014	78.15 Million TWD	41.02%
2013	55.42 Million TWD	-12.2%
2012	63.12 Million TWD	-25.31%
2011	84.5 Million TWD	31.55%
2010	64.23 Million TWD	-32.62%
2009	95.34 Million TWD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	108.8 Million TWD	56.72%
2024 Q2	82.36 Million TWD	-24.29%
2023 Q3	86.04 Million TWD	-40.21%
2023 Q2	143.92 Million TWD	16.55%
2023 Q4	69.42 Million TWD	-19.32%
2023 Q1	123.48 Million TWD	49.08%
2023 FY	69.42 Million TWD	-16.19%
2022 Q3	92.4 Million TWD	18.17%
2022 FY	82.83 Million TWD	16.19%
2022 Q4	82.83 Million TWD	-10.36%
2022 Q2	78.2 Million TWD	-17.41%
2022 Q1	94.68 Million TWD	32.81%
2021 Q2	122.82 Million TWD	13.39%
2021 Q4	71.29 Million TWD	4.55%
2021 Q1	108.32 Million TWD	29.74%
2021 FY	71.29 Million TWD	-14.61%
2021 Q3	68.19 Million TWD	-44.48%
2020 Q3	82.12 Million TWD	17.79%
2020 FY	83.49 Million TWD	16.63%
2020 Q1	76.15 Million TWD	6.38%
2020 Q2	69.71 Million TWD	-8.46%
2020 Q4	83.49 Million TWD	1.67%
2019 FY	71.58 Million TWD	5.64%
2019 Q4	71.58 Million TWD	-5.92%
2019 Q3	76.09 Million TWD	-25.74%
2019 Q1	66.03 Million TWD	-2.55%
2019 Q2	102.47 Million TWD	55.17%
2018 FY	67.76 Million TWD	-14.28%
2018 Q2	110.02 Million TWD	53.58%
2018 Q3	67.26 Million TWD	-38.87%
2018 Q1	71.63 Million TWD	-9.38%
2018 Q4	67.76 Million TWD	0.75%
2017 Q4	79.05 Million TWD	-25.89%
2017 Q2	101.98 Million TWD	23.58%
2017 FY	79.05 Million TWD	9.71%
2017 Q1	82.52 Million TWD	14.53%
2017 Q3	106.66 Million TWD	4.59%
2016 Q3	78.01 Million TWD	-27.5%
2016 FY	72.05 Million TWD	-12.5%
2016 Q4	72.05 Million TWD	-7.63%
2016 Q2	107.61 Million TWD	45.72%
2016 Q1	73.84 Million TWD	-10.33%
2015 FY	82.35 Million TWD	5.37%
2015 Q4	82.35 Million TWD	26.89%
2015 Q3	64.9 Million TWD	-51.32%
2015 Q2	133.31 Million TWD	90.1%
2015 Q1	70.13 Million TWD	-10.27%
2014 Q3	62.84 Million TWD	-51.0%
2014 FY	78.15 Million TWD	41.02%
2014 Q4	78.15 Million TWD	24.37%
2014 Q2	128.25 Million TWD	132.62%
2014 Q1	55.13 Million TWD	-0.51%
2013 Q3	50.64 Million TWD	-61.54%
2013 Q4	55.42 Million TWD	9.43%
2013 FY	55.42 Million TWD	-12.2%
2013 Q1	72.7 Million TWD	15.19%
2013 Q2	131.68 Million TWD	81.11%
2012 Q1	70.43 Million TWD	-16.65%
2012 Q4	63.12 Million TWD	-7.23%
2012 FY	63.12 Million TWD	-25.31%
2012 Q2	186.92 Million TWD	165.39%
2012 Q3	68.04 Million TWD	-63.6%
2011 Q4	84.5 Million TWD	38.21%
2011 Q1	63.35 Million TWD	-1.37%
2011 Q2	180 Million TWD	184.1%
2011 Q3	61.14 Million TWD	-66.03%
2011 FY	84.5 Million TWD	31.55%
2010 Q4	64.23 Million TWD	0.0%
2010 FY	64.23 Million TWD	-32.62%
2009 FY	95.34 Million TWD	0.0%

Peer Total Liabilities Comparison of Abnova (Taiwan) Corporation

Name	Total Liabilities	Total Liabilities Difference
Apex Biotechnology Corp.	500.07 Million TWD	86.117%
Sinphar Pharmaceutical Co.,Ltd.	2.85 Billion TWD	97.567%
Panion & Bf Biotech Inc.	1.32 Billion TWD	94.757%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	1.82 Billion TWD	96.188%
GenMont Biotech Incorporation	204.05 Million TWD	65.978%
Adimmune Corporation	3.7 Billion TWD	98.127%
Tanvex BioPharma, Inc.	1.94 Billion TWD	96.426%
Polaris Group	1.46 Billion TWD	95.26%
Energenesis Biomedical CO.,LTD.	24.58 Million TWD	-182.361%
UnicoCell Biomed Co., Ltd.	89.48 Million TWD	22.42%
PELL Bio-Med Technology Co. Ltd.	236.76 Million TWD	70.678%

Global Stocks Search

Abnova (Taiwan) Corporation (4133.TW)

Total Liabilities Summary of Abnova (Taiwan) Corporation

Annual Total Liabilities Chart of Abnova (Taiwan) Corporation (2023 - 2009)

Historical Annual Total Liabilities of Abnova (Taiwan) Corporation (2023 - 2009)

Peer Total Liabilities Comparison of Abnova (Taiwan) Corporation